Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction CancerJianming Xu, Hongyu Zhang, Yongqian Shu et al.|JAMA|2023Cited by 384
Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial.Weijian Guo, Xiaofeng Wang, Xiaodong Zhu et al.|Journal of Clinical Oncology|2021Cited by 2
Phase III Trial Comparing XELOX Regimen (Oxaliplatin Plus Capecitabine) Versus EOX Regimen (Epirubicin, Oxaliplatin and Capecitabine) as First-Line Treatment for Advanced Gastric Cancer: The EXELOX TrialXiaodong Zhu, Weijian Guo, Mingzhu Huang et al.|SSRN Electronic Journal|2021Cited by 1